These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7084140)

  • 1. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs.
    Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A
    Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration.
    Pisani F; Richens A
    Clin Pharmacokinet; 1983; 8(3):272-6. PubMed ID: 6851372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
    Streete JM; Berry DJ; Pettit LI; Newbery JE
    Ther Drug Monit; 1986; 8(2):161-5. PubMed ID: 3088778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
    Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H
    Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746
    [No Abstract]   [Full Text] [Related]  

  • 5. The disposition of primidone in elderly patients.
    Martines C; Gatti G; Sasso E; Calzetti S; Perucca E
    Br J Clin Pharmacol; 1990 Oct; 30(4):607-11. PubMed ID: 2291873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of primidone, phenylethylmalonamide, and phenobarbital in the rabbit.
    Hunt RJ; Miller KW
    Drug Metab Dispos; 1978; 6(1):75-81. PubMed ID: 23277
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylethylmalonamide (PEMA). An important metabolite of primidone.
    Baumel IP; Gallagher BB; Mattson RH
    Arch Neurol; 1972 Jul; 27(1):34-41. PubMed ID: 4626105
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose kinetics of primidone in human subjects: effect of phenytoin on formation and elimination of active metabolites of primidone, phenobarbital and phenylethylmalonamide.
    Sato J; Sekizawa Y; Yoshida A; Owada E; Sakuta N; Yoshihara M; Goto T; Kobayashi Y; Ito K
    J Pharmacobiodyn; 1992 Sep; 15(9):467-72. PubMed ID: 1287181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.
    Porro MG; Kupferberg HJ; Porter RJ; Theodore WH; Newmark ME
    Br J Clin Pharmacol; 1982 Aug; 14(2):294-7. PubMed ID: 7104185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible phenylethylmalondiamide (PEMA) intoxication.
    Stern EL
    Ann Neurol; 1977 Oct; 2(4):356-7. PubMed ID: 617272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of primidone and its metabolites, phenylethylmalonamide and phenobarbital, in the dog.
    Yeary RA
    Am J Vet Res; 1980 Oct; 41(10):1643-5. PubMed ID: 7224290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of phenylethylmalonamide (PEMA) in elderly men.
    Streete JM; Berry DJ; Newberry JE; Crome P
    Eur J Clin Pharmacol; 1987; 33(4):431-4. PubMed ID: 3443150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of phenylethylmalonamide during haemodialysis of a patient with renal failure.
    Streete JM; Berry DJ; Jones JA; Groggin MJ
    Ther Drug Monit; 1990 May; 12(3):281-3. PubMed ID: 2349613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs.
    Cunningham JG; Haidukewych D; Jensen HA
    J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of primidone and its active metabolites in the dog.
    Frey HH; Göbel W; Löscher W
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):14-30. PubMed ID: 543743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monitoring of anticonvulsant drugs: gas-chromatographic simultaneous determination of primidone, phenylethylmalonamide, carbamazepine, and diphenylhydantoin.
    Least CJ; Johnson GF; Solomon HM
    Clin Chem; 1975 Oct; 21(11):1658-62. PubMed ID: 1164796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose kinetics of primidone in acute viral hepatitis.
    Pisani F; Perucca E; Primerano G; D'Agostino AA; Petrelli RM; Fazio A; Oteri G; Di Perri R
    Eur J Clin Pharmacol; 1984; 27(4):465-9. PubMed ID: 6519155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of encapsulation of primidone on its oxidative metabolism in rats.
    Ferranti V; Chabenat C; Marchais H; Ménager S; Hue H; Orecchioni AM; Lafont O
    Drug Metabol Drug Interact; 2001; 18(3-4):191-208. PubMed ID: 11791884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between primidone, carbamazepine, and nicotinamide.
    Bourgeois BF; Dodson WE; Ferrendelli JA
    Neurology; 1982 Oct; 32(10):1122-26. PubMed ID: 6214728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.